About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Baltimore | 548 Studies

Clinical Trials Breast CancerBaltimore

Breast Cancer Clinical Trials in Baltimore

Find 548 clinical trials for breast cancer near Baltimore, Maryland. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Baltimore

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 548 trials

CompletedEvaluating Patient Information PrescriptionsResearch shows that patient satisfaction with medical care correlates strongly with how satisfied they are with the ease of getting information from their providers regarding…NCT00355381·Baltimore, Maryland CompletedCombination Immunotherapy With Herceptin and the HER2 Vaccine NeuVaxThe study will be a multi-center, prospective, randomized, single-blinded, placebo-controlled Phase II trial of Herceptin + NeuVax(TM) vaccine (E75 peptide/granulocyte…NCT01570036·Beverly Hills, California and 28 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedGCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and BiomarkersThis research is being done to find out how safe and how well the combination of lapatinib and vorinostat works against advanced cancers.NCT01118975·Baltimore, Maryland

RecruitingAssessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsThis is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are…NCT06418204·Fairbanks, Alaska and 466 others

WithdrawnMarkers for Predicting Risk of Breast Cancer in Women of Different RacesThis research is being done to learn more about the risk of developing breast cancer by studying cells from both normal breast tissue and breast cancer tumor tissue.NCT02574546·Baltimore, Maryland

RecruitingThe PREDICT Registry:This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions.NCT03448926·Scottsdale, Arizona and 29 others

Active not recruitingA Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)This Phase III, randomized, double-blind, placebo-controlled, multicenter study will evaluate the efficacy and safety of giredestrant combined with palbociclib compared with…NCT04546009·Fountain Valley, California and 254 others

CompletedDocetaxel in Treating Patients With Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003565·Anniston, Alabama and 73 others

TerminatedStudy of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)The purpose of this study is to evaluate the percentage of participants in each sotatercept dose regimen who achieve a hematopoietic response during the treatment period including…NCT00931606·Sedona, Arizona and 34 others

Active not recruitingA Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy are at higher risk of disease recurrence.NCT04622319·Anaheim, California and 481 others

RecruitingA Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain MetastasesThis study is a multicenter, two-stage clinical trial to evaluate the efficacy and safety of utidelone in combination with capecitabine in patients with HER2-negative breast…NCT06764940·Duarte, California and 11 others

Active not recruitingCediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast CancerThis partially randomized phase I/II trial studies the side effects and the best dose of cediranib maleate and olaparib and to see how well they work compared to olaparib alone in…NCT01116648·Los Angeles, California and 13 others

CompletedNutrition, Exercise, and Breast Cancer SurvivorshipThe purpose of the study is to examine the effects of resistance training on the reasons (mechanisms) underlying the development of fatigue, muscle weakness and wasting…NCT01151488·Baltimore, Maryland

CompletedSurgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00881361·Mobile, Alabama and 323 others

RecruitingA Phase I/II Study of VLS-1488 in Subjects With Advanced CancerThis is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.NCT05902988·Los Angeles, California and 13 others

CompletedAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)This is a Phase 1, open-label, dose-escalation trial of avelumab \[antibody targeting programmed death ligand 1 (anti PD-L1)\] with consecutive parallel group expansion in…NCT01772004·Goodyear, Arizona and 73 others

Active not recruitingNiraparib + Dostarlimab In BRCA Mutated Breast CancerThis research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PALB2 mutations.NCT04584255·New Haven, Connecticut and 7 others

Active not recruitingCarboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast CancerRATIONALE: Drugs used in chemotherapy, such as carboplatin and paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells…NCT00616967·Birmingham, Alabama and 4 others

RecruitingA Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationPhase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A\*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p53 R175H mutation.NCT06778863·Scottsdale, Arizona and 20 others

RecruitingPalazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerThis phase 3 clinical trial compares the efficacy and safety of palazestrant with ribociclib to letrozole and ribociclib in women and men who have not received prior systemic…NCT07085767·Hot Springs, Arkansas and 199 others

PreviousPage 8 of 28Next

Other Conditions in Baltimore

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma